NexGel (NXGL) Expected to Announce Earnings on Tuesday

NexGel (NASDAQ:NXGL) will likely be releasing its Q3 2025 results before the market opens on Tuesday, November 11th. Analysts expect NexGel to post earnings of ($0.08) per share and revenue of $3.1640 million for the quarter. Interested persons may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Tuesday, November 11, 2025 at 4:30 PM ET.

NexGel (NASDAQ:NXGL) last posted its quarterly earnings results on Tuesday, August 12th. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). NexGel had a negative return on equity of 49.37% and a negative net margin of 25.02%.The firm had revenue of $2.88 million for the quarter, compared to analysts’ expectations of $3.08 million.

NexGel Stock Down 4.3%

Shares of NXGL traded down $0.10 during midday trading on Tuesday, reaching $2.25. 21,498 shares of the stock were exchanged, compared to its average volume of 57,273. The company has a quick ratio of 0.98, a current ratio of 1.74 and a debt-to-equity ratio of 0.16. The company has a market cap of $18.32 million, a price-to-earnings ratio of -5.62 and a beta of 0.57. The firm has a 50 day simple moving average of $2.48 and a 200-day simple moving average of $2.47. NexGel has a 12-month low of $2.10 and a 12-month high of $5.10.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NexGel in a report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, NexGel presently has a consensus rating of “Sell”.

About NexGel

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.